US Bancorp’s Rein Therapeutics RNTX Stock Holding History
Bought
Maintained
Sold
Other funds holding RNTX
US Bancorp's RNTX Position: Q3 2026 in Review
US Bancorp held its Rein Therapeutics (RNTX) position steady in Q3 2026 at 1,250 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #4039.
US Bancorp first reported a position in RNTX in Q2 2019 and has held it in 30 quarters since. The position peaked at $36K in Q1 2021. 64 funds tracked by Wall St. Rank hold RNTX as of Q3 2026.
- US Bancorp held 1,250 shares of Rein Therapeutics worth $1K as of Q3 2026.
- US Bancorp left its Rein Therapeutics share count unchanged in Q3 2026.
- Rein Therapeutics made up ﹤0.01% of US Bancorp's portfolio in Q3 2026, its #4039 holding.
- US Bancorp first reported a position in Rein Therapeutics in Q2 2019 and has held it in 30 quarters since.
- US Bancorp's Rein Therapeutics position peaked at $36K in Q1 2021.
- 64 funds tracked by Wall St. Rank held Rein Therapeutics as of Q3 2026.
Based on US Bancorp's 13F filing for Q3 2026, filed 5 Nov 2026.